Mechanism of Retinal Damage in Autoimmune Retinopathy
自身免疫性视网膜病变的视网膜损伤机制
基本信息
- 批准号:7455030
- 负责人:
- 金额:$ 36.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesAntibody SpecificityAntisense OligonucleotidesApoptosisApoptoticAutoantibodiesAutoimmune ProcessBiological MarkersBlindnessBlood-Retinal BarrierCalciumCell DeathCellsCessation of lifeClinicalClinical TreatmentComplexDevelopmentElectroretinographyEvaluationEye diseasesGoalsGrantIn VitroMalignant NeoplasmsMediatingMedicalMethodsModelingNumbersPathogenicityPathway interactionsPatient CarePatientsPhenotypePhotoreceptorsPhototransductionPropertyProteinsRangeRateRattusResearch PersonnelRetinaRetinalRetinal DegenerationRetinal DiseasesRetinal Ganglion CellsRoleSerumSpecificitySymptomsTherapeutic AgentsTherapeutic InterventionTimeTissuesVisual impairmentbasecaspase-3cell typecytotoxicityenolasein vitro Modelin vivomelanomapreventprogramsrecoverin proteinresponseretinal damage
项目摘要
DESCRIPTION (provided by applicant): Retinal degeneration is one of the leading causes of visual loss in the world. Autoimmune retinopathies, including paraneoplastic retinopathies such as cancer-associated retinopathy and melanoma-associated retinopathy, are progressive visual impairments that are mediated by autoantibodies against retinal proteins. Autoimmune retinopathy is currently an untreatable eye disease, and an understanding of its pathogenicity is still incomplete.
The proposed hypothesis is that autoantibodies induce retinopathy through the activation of apoptotic death in retinal cells by increasing intracellular calcium. A massive death of retinal cells leads to significant tissue damage, loss of vision, and finally, blindness. To determine general treatment strategies, assessment is needed of a common mechanism of retinopathy that is associated with autoantibodies of various retinal specificities.
The long-term goal is to define the mechanism of retinal damage in autoimmune retinopathy and, based on these findings, to identify precise, critical time points for therapeutic intervention to treat clinical symptoms. The objectives of this proposal are to establish pathogenic properties of patients' anti-retinal antibodies using an in vivo rat model and in vitro methods, and to define clinical and electrophysiological markers (indicators) for seropositive patients in order to initiate optimum medical evaluation and care for these patients. To achieve these objectives, the following specific aims are proposed: (1) To determine whether autoantibodies of different anti-retinal specificities activate the same mechanism in initiating apoptosis in vitro, (2) To define the phenotype of retinopathy patients with specific anti-retinal autoantibodies, (3) To determine the role of autoantibodies in altering the function of retinal cells using the rat model and electroretinography, and (4) To examine possible pathways to stop apoptosis in treating retinal degeneration in the rat model of antibody-induced retinopathy.
描述(由申请人提供):视网膜变性是世界上视力丧失的主要原因之一。自身免疫性视网膜病变,包括副肿瘤视网膜病变,如癌症相关视网膜病变和黑色素瘤相关视网膜病变,是由针对视网膜蛋白的自身抗体介导的进行性视力损害。自身免疫性视网膜病变目前是一种无法治愈的眼病,对其致病性的了解仍然不完整。
项目成果
期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Electroretinographic findings in transplant chorioretinopathy.
移植脉络膜视网膜病变的视网膜电图检查结果。
- DOI:10.2147/opth.s12057
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Chan-Kai,BrianT;Yeh,Steven;Weleber,RichardG;Francis,PeterJ;Adamus,Grazyna;Witherspoon,SRobert;Lauer,AndreasK
- 通讯作者:Lauer,AndreasK
Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.
自身抗体靶标及其在副肿瘤性视网膜病的致病性中的癌症关系。
- DOI:10.1016/j.autrev.2009.01.002
- 发表时间:2009-03
- 期刊:
- 影响因子:13.6
- 作者:Adamus, Grazyna
- 通讯作者:Adamus, Grazyna
Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies.
- DOI:10.1016/j.yexmp.2009.08.003
- 发表时间:2009-12
- 期刊:
- 影响因子:3.6
- 作者:Adamus, Grazyna;Brown, Lori;Weleber, Richard G.
- 通讯作者:Weleber, Richard G.
Antirecoverin antibodies and autoimmune retinopathy.
抗恢复蛋白抗体和自身免疫性视网膜病变。
- DOI:10.1001/archopht.118.11.1577
- 发表时间:2000
- 期刊:
- 影响因子:0
- 作者:Adamus,G
- 通讯作者:Adamus,G
Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss.
与前列腺癌相关的双侧副肿瘤性视神经病变和单侧视网膜损害:对不明原因视力丧失患者的鉴别诊断挑战。
- DOI:10.1007/s10633-012-9327-0
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Carboni,Giovannella;Forma,Gina;Bond,AprilD;Adamus,Grazyna;Iannaccone,Alessandro
- 通讯作者:Iannaccone,Alessandro
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GRAZYNA ADAMUS其他文献
GRAZYNA ADAMUS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GRAZYNA ADAMUS', 18)}}的其他基金
Recombinant T-cell Receptor Ligands for Treatment of Uveitis
用于治疗葡萄膜炎的重组 T 细胞受体配体
- 批准号:
7157641 - 财政年份:2006
- 资助金额:
$ 36.93万 - 项目类别:
TRAINING OF INDIA OR CHINA PERSONNEL IN PRIMATOLOGY
对印度或中国人员进行灵长类动物学培训
- 批准号:
7165282 - 财政年份:2005
- 资助金额:
$ 36.93万 - 项目类别:
Mechanism of Retinal Damage in Autoimmune Retinopathy
自身免疫性视网膜病变的视网膜损伤机制
- 批准号:
7250134 - 财政年份:1999
- 资助金额:
$ 36.93万 - 项目类别:
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY
自身免疫性视网膜病视网膜损伤的机制
- 批准号:
6525150 - 财政年份:1999
- 资助金额:
$ 36.93万 - 项目类别:
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY
自身免疫性视网膜病视网膜损伤的机制
- 批准号:
6179807 - 财政年份:1999
- 资助金额:
$ 36.93万 - 项目类别:
Mechanism of Retinal Damage in Autoimmune Retinopathy
自身免疫性视网膜病变的视网膜损伤机制
- 批准号:
7104942 - 财政年份:1999
- 资助金额:
$ 36.93万 - 项目类别:
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY
自身免疫性视网膜病视网膜损伤的机制
- 批准号:
6652649 - 财政年份:1999
- 资助金额:
$ 36.93万 - 项目类别:
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY
自身免疫性视网膜病视网膜损伤的机制
- 批准号:
6384887 - 财政年份:1999
- 资助金额:
$ 36.93万 - 项目类别:
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY
自身免疫性视网膜病视网膜损伤的机制
- 批准号:
6080469 - 财政年份:1999
- 资助金额:
$ 36.93万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 36.93万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 36.93万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 36.93万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 36.93万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 36.93万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 36.93万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 36.93万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 36.93万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 36.93万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 36.93万 - 项目类别: